The effect of protein kinase C-delta knockdown on anti-free radical enzyme and neuropeptide y gene expression in phenylpropanolamine-treated rats

Journal of Neurochemistry

Volumn 114, Issue 4, 2010, Pages 1217-1230

  Kuo, Dong Yih ^a   Yang, Shun Fa ^a   Chu, Shu Chen ^b   Chen, Chin Hsiu ^a   Chen, Pei Ni ^a   Hsieh, Yih Shou ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

brain; feeding; free radical; NPY; phenylpropanolamine; PKC

Indexed keywords

CATALASE; ENZYME INHIBITOR; FREE RADICAL; NEUROPEPTIDE Y; NITROGEN OXIDE SYNTHASE; PHENYLPROPANOLAMINE; PROTEIN KINASE C DELTA; SYNTHETASE; UNCLASSIFIED DRUG; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; GENE EXPRESSION REGULATION; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; EATING; ENZYMOLOGY; GENETICS; HYPOTHALAMUS; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; ANOREXIA; CATALASE; DISEASE MODELS, ANIMAL; EATING; FREE RADICALS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; OXIDATIVE STRESS; PHENYLPROPANOLAMINE; PROTEIN KINASE C-DELTA; RATS; RATS, WISTAR;

EID: 77954730153     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06843.x     Document Type: Article

References (81)

1. Alexander M., Rothman R. B., Baumann M. H., Endres C. J., Brasic J. R. Wong D. F. (2005) Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis. Synapse 56, 94 99.
2. Allen J. M., Yeats J. C., Adrian T. E. Bloom S. R. (1984) Radioimmunoassay of neuropeptide Y. Regul. Peptides 8, 61 70.
3. Bashkatova V., Kraus M. M., Hornick A., Philippi A. Prast H. (2005) 7-nitroindazole, nNOS inhibitor, attenuates amphetamine-induced amino acid release and nitric oxide generation but not lipid peroxidation in the rat brain. J. Neural. Transm. 112, 779 788.
4. Battaini F. (2001) Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol. Res. 44, 353 361.
5. Bon C. L. Garthwaite J. (2003) On the role of nitric oxide in hippocampal long-term potentiation. J. Neurosci. 23, 1941 1948.
6. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
7. Budas G. R., Koyanagi T., Churchill E. N. Mochly-Rosen D. (2007) Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic. Biochem. Soc. Trans. 35, 1021 1026.
8. Bustamante J., Czerniczyniec A., Cymeryng C. Lores-Arnaiz S. (2008) Age related changes from youth to adulthood in rat brain cortex: nitric oxide synthase and mitochondrial respiratory function. Neurochem. Res. 33, 1216 1223.
9. Cao G., Gardner A. Westfall T. C. (2007) Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells). Biochem. Pharmacol. 73, 1446 1454.
10. Castro A. A., Moretti M., Casagrande T. S. et al. (2009) Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. Pharmacol. Biochem. Behav. 91, 636 642.
11. Chang J. Y. Liu L. Z. (2000) Catecholamines inhibit microglial nitric oxide production. Brain Res. Bull. 52, 525 530.
12. Chee M. J. Colmers W. F. (2008) Y eat? Nutrition 24, 869 877.
13. Cheng J. T. Kuo D. Y. (2003) Both 1-adrenergic and D1-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. Neurosci. Lett. 347, 136 138.
14. Chomczynski P. Sacchi N. (1987) Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156 159.
15. Churruca I., Portillo M. P., Casis L., Gutiérrez A., Macarulla M. T. Echevarría E. (2008) Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats. Neuropeptides 42, 293 299.
16. Coderre T. J. (1994) The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol. Neurobiol. 7, 229 246.
17. Crowley W. R., Ramoz G., Keefe K. A., Torto R., Kalra S. P. Hanson G. R. (2005) Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats. Neuroscience 132, 167 173.
18. Cvijic G., Djordjevic J. Davidovic V. (2000) Effect of fasting and refeeding on the activities of monoamine oxidase and antioxidant enzymes in rat hypothalamus and brown adipose tissue. Gen. Physiol. Biophys. 19, 305 316.
19. Cvijić G., Radojicić R., Djordjević J. Davidović V. (1995) The effect of glucocorticoids on the activity of monoamine oxidase, copper-zinc superoxide dismutase and catalase in the rat hypothalamus. Funct. Neurol. 10, 175 181.
20. Figueredo-Cardenas G., Morello M., Sancesario G., Bernardi G. Reiner A. (1996) Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res. 735, 317 324.
21. Frazier D. P., Wilson A., Dougherty C. J., Li H., Bishopric N. H. Webster K. A. (2007) PKC-alpha and TAK-1 are intermediates in the activation of c-Jun NH2-terminal kinase by hypoxia-reoxygenation. Am. J. Physiol.-Heart Circ. Physiol. 292, H1675 H1684.
22. Frey B. N., Valvassori S. S., Réus G. Z., Martins M. R., Petronilho F. C., Bardini K., Dal-Pizzol F., Kapczinski F. Quevedo J. (2006) Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem. Res. 31, 699 703.
23. Garthwaite J. (2008) Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci. 27, 2783 2802.
24. Ghosh M. K., Ghosh K., Dahl O. Cohen J. S. (1993) Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application. Nucleic Acids Res. 21, 5761 5766.
25. Giambalvo C. T. (1992) Protein kinase C and dopamine transport - 1. Effects of amphetamine in vivo. Neuropharmacology 31, 1201 1210.
26. Giambalvo C. T. (2004) Mechanisms underlying the effects of amphetamine on particulate PKC activity. Synapse 51, 128 139.
27. Goodhue A., Bartel R. L. Smith N. B. (2000) Exacerbation of psychosis by phenylpropanolamine. Am. J. Psychiatry 157, 1021 1022.
28. Horvath T. L., Andrews Z. B. Diano S. (2009) Fuel utilization by hypothalamic neurons: roles for ROS. Trends Endocrinol. Metab. 20, 78 87.
29. Hsieh Y. S., Yang S. F., Chiou H. L. Kuo D. Y. (2005) Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression. Eur. J. Neurosci. 22, 715 723.
30. Hsieh Y. S., Yang S. F., Chiou H. L. Kuo D. Y. (2006) Activations of c- c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Toxicol. Appl. Pharm. 212, 99 109.
31. Hsieh Y. S., Yang S. F., Chiou H. L. Kuo D. Y. (2007a) Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression. Behav. Neurosci. 211, 933 940.
32. Hsieh Y. S., Yang S. F., Chu S. C. Kuo D. Y. (2007b) Transcript of protein kinase A knock down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats. Physiol. Genomics 31, 306 314.
33. Hsieh Y. S., Yang S. F. Kuo D. Y. (2007c) Intracerebral administration of protein kinase A or c-AMP response element binding protein antisense oligonucleiotide can modulate amphetamine-mediated appetite suppression in free-moving rats. Am. J. Physiol-Endoc. Metab. 292, 123 131.
34. Hsieh Y. S., Yang S. F., Chu S. C., Ho Y. J., Kuo C. S. Kuo D. Y. (2008) Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats. J. Neurochem. 105, 1438 1449.
35. Ioannides-Demos L. L., Proietto J. McNeil J. J. (2005) Pharmacotherapy for obesity. Drugs 65, 1391 1418.
36. Jung E. Y., Suh H. J., Kim S. Y., Hong Y. S., Kim M. J. Chang U. J. (2008) Appetite suppressive effects of yeast hydrolysate on nitric oxide synthase (NOS) expression and vasoactive intestinal peptide (VIP) immunoreactivity in hypothalamus. Phytother. Res. 22, 1417 1422.
37. Kaul S., Kanthasamy A., Kitazawa M., Anantharam V. Kanthasamy A. G. (2003) Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur. J. Neurosci. 18, 1387 1401.
38. Kim E. H., Shin M. S., Chang H. K., Lee T. H., Jang M. H., Shin M. C., Lee S. J. Kim C. J. (2004) Aqueous extract of ma huang suppresses neuropeptide Y expression in food-deprived rat hypothalamus. Am. J. Chin. Med. 32, 659 667.
39. Kitazawa M., Anantharam V. Kanthasamy A. G. (2003) Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 119, 945 964.
40. Kolár F., Jezková J., Balková P. et al. (2007) Role of oxidative stress in PKC-delta upregulation and cardioprotection induced by chronic intermittent hypoxia. Am. J. Physiol-Heart Circ. Physiol. 292, H224 H230.
41. Kuo D. Y. Cheng J. T. (2002) Role of cerebral dopamine but not plasma insulin, leptin and glucocorticoid in the development of tolerance to the anorectic effect of amphetamine. Neurosci. Res. 44, 63 69.
42. Kuo D. Y., Yang S. F., Chu S. C., Chen C. H. Hsieh Y. S. (2009a) Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling. Chem.-Bio. Int. 180, 193 201.
43. Kuo D. Y., Yang S. F., Chu S. C., Chen C. H. Hsieh Y. S. (2009b) Roles of protein kinase C- isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression. J. Neurochem. 108, 1495 1506.
44. Kuri B. A., Khan S. A., Chan S. A., Prabhakar N. R. Smith C. B. (2007) Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase C. J. Physiol. 584, 313 319.
45. Lee S. J., Kim D. C., Choi B. H., Ha H. Kim K. T. (2006) Regulation of p53 by activated protein kinase C-delta during nitric oxide-induced dopaminergic cell death. J. Biol. Chem. 281, 2215 2224.
46. Levin O. S. (2005) "Ephedron" encephalopathy. Zh Nevrol Psikhiatr Im S S Korsakova. (Russia) 105, 12 20.
47. Liedtke C. M. Cole T. (1997) Antisense oligodeoxynucleotide to PKC-delta blocks alpha 1-adrenergic activation of Na-K-2Cl cotransport. Am. J. Physiol. 273, C1632 C1640.
48. Lowry O. H., Rosebrough N. J., Farr A. L. Randall R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265 275.
49. Moore P. K. Handy R. L. (1997) Selective inhibitors of neuronal nitric oxide synthase - is no NOS really good NOS for the nervous system. Trends Pharmacol. Sci. 18, 204 211.
50. Morita M., Matsuzaki H., Yamamoto T., Fukami Y. Kikkawa U. (2008) Epidermal growth factor receptor phosphorylates protein kinase C delta at Tyr332 to form a trimeric complex with p66Shc in the H2O2-stimulated cells. J. Biochem. (Tokyo) 143, 31 38.
51. Morley J. E., Kumar V. B., Mattammal M. Villareal D. T. (1995) Measurement of nitric oxide synthase and its mRNA in genetically obese (obob) mice. Life Sci. 57, 1327 1331.
52. Morley J. E., Alshaher M. M., Farr S. A., Flood J. F. Kumar V. B. (1999) Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding. Peptides 20, 595 600.
53. Morris B. J. (1989) Neuronal localization of neuropeptide Y gene expression in rat brain. J. Comp. Neurol. 290, 358 368.
54. Newton P. M. Ron D. (2007) Protein kinase C and alcohol addiction. Pharmacol. Res. 55, 570 577.
55. Ogawa S. Pfaff D. W. (1998) Current status of antisense DNA methods in behavioral studies. Chem. Senses 23, 249 255.
56. Ogita K., Miyamoto S., Yamaguchi K., Koide H., Fujisawa N., Kikkawa U., Sahara S., Fukami Y. Nishizuka Y. (1992) Isolation and characterization of delta-subspecies of protein kinase C from rat brain. Proc. Natl Acad. Sci. USA 89, 1592 1596.
57. Olive M. F. Messing R. O. (2004) Protein kinase C isozymes and addiction. Mol. Neurobiol. 29, 139 154.
58. Paxinos G. Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press
59. Penzner J. H., Thompson D. L., Arth C., Fowler J. K., Ary A. W. Szumlinski K. K. (2008) Protracted 'anti-addictive' effects of adolescent phenylpropanolamine exposure in C57BL6J mice. Addict. Biol. 13, 310 325.
60. Pilsczek F. H., Karcic A. A. Freeman I. (2003) Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction. Heart Lung 32, 100 104.
61. Ritter R. C., Slusser P. G. Stone S. (1981) Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213, 451 452.
62. Song X., Mosby N., Yang J., Xu A., Abdel-Malek Z. Kadekaro A. L. (2009) Alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res. 22, 809 818.
63. Stier B. G. Hennekens C. H. (2006) Phenylpropanolamine and hemorrhagic stroke in the Hemorrhagic Stroke Project: a reappraisal in the context of science, the Food and Drug Administration, and the law. Ann. Epidemiol. 16, 49 52.
64. Szumlinski K. K., Liu A., Penzner J. H. Lominac K. D. (2007) Protracted 'pro-addictive' phenotype produced in mice by pre-adolescent phenylpropanolamine. Neuropsychopharmacology 32, 1760 1773.
65. Tejada S., Sureda A., Roca C., Gamundí A. Esteban S. (2007) Antioxidant response and oxidative damage in brain cortex after high dose of pilocarpine. Brain Res. Bull. 71, 372 375.
66. Toker A. (1998) Signaling through protein kinase C. Front Biosci. 3, D1134 D1147.
67. Toll K. Graf P. (2006) Phenylpropanolamine's decongestive effect on the nasalmucosa of pregnant women with nasal stuffiness. Rhinology 44, 274 277.
68. Tomimatsu N. Arakawa Y. (2008) Protein kinase C-mediated protection of motoneurons from excitotoxicity. Neurosci. Lett. 439, 143 146.
69. Tsakiris P., de la Rosette J. J., Michel M. C. Oelke M. (2008) Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur. Urol. 53, 53 59.
70. Vozzo R., Wittert G. A., Horowitz M., Morley J. E. Chapman I. M. (1999) Effect of nitric oxide synthase inhibitors on short-term appetite and food intake in humans. Am. J. Physiol. 276, R1562 R1568.
71. Wachira S. J., Hughes-Darden C. A., Taylor C. V., Ochillo R. Robinson T. J. (2003) Evidence for the interaction of protein kinase C and melanocortin 3-receptor signaling pathways. Neuropeptides 37, 201 210.
72. Wellman P. J. Davies B. T. (1992) Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the 1-adrenergic receptor antagonist prazosin. Pharmacol. Biochem. Behav. 42, 97 100.
73. Widnell K. L., Self D. W., Lane S. B., Russell D. S., Vaidya V., Miserendino M. J. D., Rubin C. S., Duman R. S. Nestler E. J. (1996) Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276, 306 315.
74. Williams G., Bing C., Cai X. J., Harrold J. A., King P. J. Liu X. H. (2001) The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol. Behav. 74, 683 701.
75. Wynne K., Stanley S., McGowan B. Bloom S. (2005) Appetite control. J. Endocrinol. 184, 291 318.
76. Yoon B. W., Bae H. J., Hong K. S. et al. (2007) Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke. Neurology 9, 146 149.
77. Yuan J., Callahan B. T., McCann U. D. Ricaurte G. A. (2001) Evidence against an essential role of endogenous brain dopamine in methamphetamine- induced dopaminergic neurotoxicity. J. Neurochem. 77, 1338 1347.
78. Zaloga G. P., Clark J. D. Roberts R. (2000) Inhibition of nitric oxide synthase enhances the myocardial toxicity of phenylpropanolamine. Crit. Care Med. 28, 3679 3683.
79. Zhang M. Creese I. (1993) Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci. Lett. 161, 223 226.
80. Zhang D., Anantharam V., Kanthasamy A. Kanthasamy A. G. (2007a) Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J. Pharmacol. Exp. Ther. 322, 913 922.
81. Zhang D., Kanthasamy A., Yang Y., Anantharam V. Kanthasamy A. (2007b) Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J. Neurosci. 27, 5349 5362.